Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme at NCMM will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.
Professor Janna Saarela joined NCMM as Director in January 2019. She was previously head of the Technology Centre and Deputy Director of the Institute for Molecular Medicine Finland (FIMM), which is also part of the Nordic EMBL Partnership. Here she shares some insight into her research, and what she hopes the future holds for NCMM.
Marieke Kuijjer started at NCMM as Group Leader for Computational Biology and Systems Medicine in October 2018.
Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for researchers.
Professor Kjetil Taskén is head of the Signalling Networks in Health and Disease Group at NCMM. Here he shares some insight into his group's work with Precision Medicine and Cancer Drug Sensitivity Screening.
The Autophagy Team at NCMM studies processes that lead to intracellular degradation of cytoplasm, collectively referred to as autophagy, or 'self eating'. The team is particularly interested in the role of autophagy in aspects relating to cancer.
Anthony Mathelier's group aims to develop novel bioinformatics tools to aid patient care - We want to create the next generation of cutting-edge algorithms and open computational biology software which have immediate application to real-life biological problems, Mathelier says.
The new group leader at NCMM is one of the few in the world within the research theme of surface-adhered artificial cells. - I am trying to understand what is not driven by its genetic machinery but mostly by the materials properties, Gözen says.